GS
NVO

GTS Securities’s Novo Nordisk NVO Stock Holding History

GTS Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-96,000
Closed -$11.4M – 3153
2024
Q3 		$11.4M Buy
96,000
+8,000
+9% +$1.07M 0.02% 454
2024
Q2 		$12.6M Buy
88,000
+6,800
+8% +$901K 0.03% 407
2024
Q1 		$10.4M Sell
81,200
-36,300
-31% -$4.32M 0.02% 491
2023
Q4 		$12.2M Sell
117,500
-43,700
-27% -$4.32M 0.02% 529
2023
Q3 		$14.7M Buy
+161,200
New +$14.2M 0.03% 442

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

GTS Securities's NVO Position: Q1 2026 in Review

GTS Securities sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,391 shares — an estimated $223K sold.

GTS Securities first reported a position in NVO in Q2 2023 and held it in 9 quarters. The position peaked at $3.6M in Q1 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • GTS Securities reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 4,391 Novo Nordisk shares in Q1 2026, an estimated $223K.
  • GTS Securities first reported a position in Novo Nordisk in Q2 2023 and held it in 9 quarters.
  • GTS Securities's Novo Nordisk position peaked at $3.6M in Q1 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.